No products in the cart.
Rabbit Polyclonal Phospho-Neu (Y1112) antibody (STJ90573)
Supplier: St John’s Laboratory Ltd.
Recommended applications: WB, ELISA
Recommended dilution: WB 1:500-1:2000; ELISA 1:10000;
Recommended protocols: check protocols
Click or hover above images to see image description for Neu (phospho Tyr1112) Polyclonal Antibody.
Check alternative names for the antibodyExpand
ERBB2 antibody, HER2 antibody, MLN19 antibody, NEU antibody, NGL antibody,|Verb b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog antibody|C erb B2/neu protein antibody|CD340 antibody|CD340 antigen antibody|Cerb B2/neu protein antibody|CerbB2 antibody|Erb b2 receptor tyrosine kinase 2 antibody|ERBB2 antibody|ERBB2_HUMAN antibody|HER 2 antibody|HER 2/NEU antibody|HER2 antibody|Herstatin antibody|Human epidermal growth factor receptor 2 antibody|Metastatic lymph node gene 19 protein antibody|MLN 19 antibody|MLN19 antibody|NEU antibody|NEU proto oncogene antibody|Neuro/glioblastoma derived oncogene homolog antibody|Neuroblastoma/glioblastoma derived oncogene homolog antibody|NGL antibody|p185erbB2 antibody|Proto-oncogene c-ErbB-2 antibody|Proto-oncogene Neu antibody|Receptor tyrosine-protein kinase erbB-2 antibody|TKR1 antibody|Tyrosine kinase type cell surface receptor HER2 antibody|Tyrosine kinase-type cell surface receptor HER2 antibody|V erb b2 avian erythroblastic leukemia viral oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog) antibody|V erb b2 avian erythroblastic leukemia viral oncogene homolog 2 antibody|V erb b2 avian erythroblastic leukemia viral oncoprotein 2 antibody|V erb b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) antibody|V erb b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog antibody|Verb b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) antibody|Anti-ErbB 2 antibody [3B5] (ab16901)
SCBT cat No: sc-71667|sc-23864|sc-33684|sc-136294|sc-08|sc-393712|sc-374382|sc-31154|sc-284|sc-377344|sc-52349|sc-31153|sc-7301|sc-134481|sc-166824|sc-32936|sc-25905|sc-25906|sc-100570|sc-366571|sc-161126|sc-161127|sc-136327|sc-377407|
Neu (phospho Tyr1112) Polyclonal Antibody
|Catalogue No.|| |
Human, Mouse, Rat
Phospho-Neu (Y1112) Polyclonal Antibody detects endogenous levels of Neu protein only when phosphorylated at Y1112.
Synthesized phospho-peptide derived from Neu (phospho Tyr1112) at AA range 1050-1130
|Recommended dilution|| |
WB 1:500-1:2000; ELISA 1:10000;
|Molecular weight|| |
Neu (phospho Tyr1112) Antibody was tube-contained. Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Neu (phospho Tyr1112) Antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-20 Celsius degree. Avoid repeated freeze/thaw cycles.
|Alternative antibody names|| |
Receptor tyrosine-protein kinase erbB-2 antibody, Metastatic lymph node gene 19 protein antibody, MLN 19 antibody, Proto-oncogene Neu antibody, Proto-oncogene c-ErbB-2 antibody, Tyrosine kinase-type cell surface receptor HER2 antibody, p185erbB2 antibody, CD antigen CD340 antibody
|Protein names|| |
Receptor tyrosine-protein kinase erbB-2 , Metastatic lymph node gene 19 protein , MLN 19 , Proto-oncogene Neu , Proto-oncogene c-ErbB-2 , Tyrosine kinase-type cell surface receptor HER2 , p185erbB2 , CD antigen CD340
|Involvement in disease|| |
Hereditary diffuse gastric cancer (HDGC) [MIM:137215]: A cancer predisposition syndrome with increased susceptibility to diffuse gastric cancer. Diffuse gastric cancer is a malignant disease characterized by poorly differentiated infiltrating lesions resulting in thickening of the stomach. Malignant tumors start in the stomach, can spread to the esophagus or the small intestine, and can extend through the stomach wall to nearby lymph nodes and organs. It also can metastasize to other parts of the body. Note: The gene represented in this entry is involved in disease pathogenesis.; Glioma (GLM) [MIM:137800]: Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes. Note: The gene represented in this entry is involved in disease pathogenesis.; Ovarian cancer (OC) [MIM:167000]: The term ovarian cancer defines malignancies originating from ovarian tissue. Although many histologic types of ovarian tumors have been described, epithelial ovarian carcinoma is the most common form. Ovarian cancers are often asymptomatic and the recognized signs and symptoms, even of late-stage disease, are vague. Consequently, most patients are diagnosed with advanced disease. Note: Disease susceptibility is associated with variations affecting the gene represented in this entry.; Lung cancer (LNCR) [MIM:211980]: A common malignancy affecting tissues of the lung. The most common form of lung cancer is non-small cell lung cancer (NSCLC) that can be divided into 3 major histologic subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung cancer. NSCLC is often diagnosed at an advanced stage and has a poor prognosis. Note: The gene represented in this entry is involved in disease pathogenesis.; Gastric cancer (GASC) [MIM:613659]: A malignant disease which starts in the stomach, can spread to the esophagus or the small intestine, and can extend through the stomach wall to nearby lymph nodes and organs. It also can metastasize to other parts of the body. The term gastric cancer or gastric carcinoma refers to adenocarcinoma of the stomach that accounts for most of all gastric malignant tumors. Two main histologic types are recognized, diffuse type and intestinal type carcinomas. Diffuse tumors are poorly differentiated infiltrating lesions, resulting in thickening of the stomach. In contrast, intestinal tumors are usually exophytic, often ulcerating, and associated with intestinal metaplasia of the stomach, most often observed in sporadic disease. Note: The gene represented in this entry is involved in disease pathogenesis.; Note: Chromosomal aberrations involving ERBB2 may be a cause gastric cancer. Deletions within 17q12 region producing fusion transcripts with CDK12, leading to CDK12-ERBB2 fusion leading to truncated CDK12 protein not in-frame with ERBB2.
AntibodyPlus can customize Neu (phospho Tyr1112) Antibody according to your requirement, including bulk product size,etc. Please contact firstname.lastname@example.org. AntibodyPlus provide antibody trial sample for your own antibody validation and collects antibody reviews.
St John’s Laboratory Ltd.
|Product type|| |
There are no reviews for this product yet.
By submitting a review, get following benefits:
1. Receive $50 ABcoins as credit for each review.
2. First trial sample order will be fully refunded as credit.
3. Have a chance to win a $50 amazon gift card!
There is no extra validation for this product yet.
Check other extra validated antibodies below: